Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

Completed · Not applicable

Conditions studied: Cancer

In brief

This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.

Key facts

Study ID

NCT02550925

Run by

University of Colorado, Boulder

People needed

139

Starts

2015-09-01

Expected to finish

2019-12-31

Last updated by the study team

2020-03-26

Who can join

Age: 21 and older, up to 95. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults in the Greater Boulder/ Denver, Colorado area who had cancer and completed primary cancer treatment (surgery, chemotherapy, and/or radiation) within the previous 18 months
• For solid tumor cancers: Show no current evidence of disease for solid-tumor cancers (of any cancer type or initial stage). For lymphoproliferative disorders such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma: In remission or asymptomatic after initial treatment and are followed with active surveillance.
• Screen positive for anxiety symptoms on the study screener
• Able to speak, read, and write English fluently
• Willing and able to participate in an ACT group once a week for 7 weeks
• Willing and able to complete online questionnaires and phone interviews at designated assessment points

You may not qualify if…

• Current moderate to high suicide risk
• History of chronic untreated trauma (unrelated to their cancer)
• Psychiatric hospitalization or suicide attempt in the past 5 years

Where it is running

• University of Colorado Boulder — Boulder, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.